2018
DOI: 10.1159/000490096
|View full text |Cite
|
Sign up to set email alerts
|

A Small Bowel Ulcer due to Clopidogrel with Cytomegalovirus Enteritis Diagnosed by Capsule and Double-Balloon Endoscopy

Abstract: We report the first case of small bowel ulcers due to clopidogrel in a 74-year-old man. He presented with diarrhea and melena after having been taking low-dose aspirin (LDA) and clopidogrel. There was no evidence of bleeding in the stomach, duodenum, or colon. Capsule endoscopy showed multiple ulcers and erosions in the small intestine. Double-balloon endoscopy revealed multiple ulcers throughout the ileum. Examination of the biopsy specimen showed cytomegalovirus infection. His LDA was discontinued and he was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…It became possible to examine the small intestine through as double balloon endoscopy and capsule endoscopy[ 8 , 9 ].According to previous studies, the incidence of small bowel ulcers and bleeding due to NSAIDs was about eight times higher than that of patients who did not take NSAIDs[ 10 ]. Low-dose aspirin has been reported to cause small bowel injury and 57.6% of the chronic users had mucosal breaks[ 11 ]. The crude risk of GI events in patients taking no antiplatelet therapy was 1.6%.…”
Section: Discussionmentioning
confidence: 99%
“…It became possible to examine the small intestine through as double balloon endoscopy and capsule endoscopy[ 8 , 9 ].According to previous studies, the incidence of small bowel ulcers and bleeding due to NSAIDs was about eight times higher than that of patients who did not take NSAIDs[ 10 ]. Low-dose aspirin has been reported to cause small bowel injury and 57.6% of the chronic users had mucosal breaks[ 11 ]. The crude risk of GI events in patients taking no antiplatelet therapy was 1.6%.…”
Section: Discussionmentioning
confidence: 99%